ACS Creates $1 Billion Nationwide Organization, Taking Fiduciary Control From 12 Divisions
With No Budget in Sight, NCI Takes Careful Steps; Success Rate Last Year Was 14 percent
FDA Revokes Avastin’s Accelerated Approval In Metastatic Breast Cancer Indication
Industry Groups Lobby for Lower Standards for FDA Approval
Trending Stories
- Supreme Court removes “Chevron deference,” threatening drug regulation, health coverage, delivery of cancer care
- In 1971, Chris Lundy had minute odds of survival. He is now the longest living BMT recipient at the Hutch
- Elizabeth Comen joins NYU Langone Health’s Perlmutter Cancer Center
- A modest proposal from a former FDA commissioner: Add antidepressants to the nation’s water supply
Warning: This is not a public health recommendation. Do not implement. - At Lung SPORE Workshop, experts reflect on the significance of discovery of EGFR mutations two decades ago
- The early days of EGFR: Herbst, Haber, Meyerson, Pao, Sequist present at Yale SPORE workshop